Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor–T Cell Therapy for Hematological Malignant Neoplasms
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.8161
Abstract: Key Points Question What is the proportion of Black participants enrolled in pivotal clinical trials supporting US Food and Drug Administration approval of chimeric antigen receptor–T cell (CAR-T) therapy for hematological malignant neoplasms? Findings In… read more here.
Keywords: clinical trials; food drug; malignant neoplasms; black participants ... See more keywords